glp-1 how does it work Part 1 of a 3-Part Series; Medications for Weight Loss GLP-1 Receptor Agonists as Treatments
Description
GLP-1 receptor agonist tachyphylaxis and perioperative recommendations
41 Clinical studies have demonstrated that CR-induced weight loss influences BMD in a time- and site-dependent manner
Action Step: Plan time and emotional energy for medication management
The dosage may be increased to 9 mg, 14.5 mg, or 17.2 mg after at least 30 days at each level based on treatment response and tolerability, according to the FDA
